Answers are grounded in this paper and cite their sources.
Case report demonstrates rapid resolution of metoclopramide-induced neuroleptic malignant syndrome with intravenous dantrolene, highlighting its life-saving potential.
We report a case of fulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six-hourly intravenous metoclopramide. The muscle rigidity and hyperpyrexia were unresponsive to intravenous benztropine but resolved within one hour of intravenous dantrolene 2 mg/kg. Within six hours the patient had a partial relapse which resolved completely following further intravenous dantrolene 2 mg/kg. This case demonstrates that the rapid effect of intravenous dantrolene can be life saving in fulminant neuroleptic malignant syndrome.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: